Premium
Prosthodontic Treatment of a Class IV ACP PDI Patient, with Langerhans Cell Histiocytosis (LCH)
Author(s) -
Papavasiliou George,
Kamposiora Phophi,
Sklavounou Alexandra,
Christopoulos Panos
Publication year - 2011
Publication title -
journal of prosthodontics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.902
H-Index - 60
eISSN - 1532-849X
pISSN - 1059-941X
DOI - 10.1111/j.1532-849x.2011.00702.x
Subject(s) - langerhans cell histiocytosis , medicine , histiocytosis , dermatology , dentistry , pathology , disease
Langerhans cell histiocytosis (LCH) is a disease of unknown etiology with a frustrating and unpredictable course. Surviving adult patients suffering from the multisystem type of the disease present with problems in most organs. This article presents the oral rehabilitation of a 28‐year‐old patient, with multisystem sequelae that included the oral cavity, classifying him as a Class IV American College of Prosthodontists Prosthodontic Diagnostic Index patient. A 5‐year course of treatment is analyzed, starting from merely replacing missing teeth with a removable partial denture. The second stage of prosthetic rehabilitation included replacement of the removable prosthesis with fixed partial dentures. The final and most important aspect of treatment was the 2‐year follow‐up, when the patient presented with no problems or adverse effects. The purpose of this presentation is to offer an insight to prosthodontic treatment possibilities for patients suffering from multisystem LCH and to show the value of a “team approach” to achieving a positive outcome.